Capricor Therapeutics, Inc.

DB:4LN2 Stock Report

Market Cap: €813.0m

Capricor Therapeutics Management

Management criteria checks 4/4

Capricor Therapeutics' CEO is Linda Marbán, appointed in Jan 2010, has a tenure of 14.83 years. total yearly compensation is $747.32K, comprised of 29.5% salary and 70.5% bonuses, including company stock and options. directly owns 0.44% of the company’s shares, worth €3.57M. The average tenure of the management team and the board of directors is 12.7 years and 11 years respectively.

Key information

Linda Marbán

Chief executive officer

US$747.3k

Total compensation

CEO salary percentage29.5%
CEO tenure14.8yrs
CEO ownership0.4%
Management average tenure12.7yrs
Board average tenure11yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Linda Marbán's remuneration changed compared to Capricor Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$34m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$747kUS$221k

-US$22m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$210k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$23m

Dec 31 2021US$2mUS$200k

-US$20m

Sep 30 2021n/an/a

-US$18m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$17m

Dec 31 2020US$2mUS$150k

-US$14m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$229kUS$157k

-US$8m

Sep 30 2019n/an/a

-US$9m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$377kUS$233k

-US$15m

Sep 30 2018n/an/a

US$374k

Jun 30 2018n/an/a

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$602kUS$233k

US$2m

Compensation vs Market: Linda's total compensation ($USD747.32K) is below average for companies of similar size in the German market ($USD1.46M).

Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.

CEO

Linda Marbán (61 yo)

14.8yrs

Tenure

US$747,315

Compensation

Dr. Linda Marbán, Ph.D. Co-founded Capricor Therapeutics, Inc. (also known as Capricor, Inc). in 2005 and also has been its Chief Executive Officer since 2010 and serves as its President. Dr. Marbán has be...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
€ 2.4m
Linda Marbán
Co-Founder14.8yrsUS$747.32k0.44%
€ 3.6m
Anthony Bergmann
CFO & Corporate Treasurer6.8yrsUS$730.85k0.0052%
€ 42.6k
Karen Krasney
Executive VP12.7yrsUS$740.77k0.044%
€ 358.5k
Kristi A. Elliott
Chief Science Officerno datano datano data
Catherine Kelleher
Consultantno datano datano data

12.7yrs

Average Tenure

64.5yo

Average Age

Experienced Management: 4LN2's management team is seasoned and experienced (12.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
€ 2.4m
Linda Marbán
Co-Founder11yrsUS$747.32k0.44%
€ 3.6m
George Dunbar
Independent Director11yrsUS$211.13k0.023%
€ 188.8k
Earl Collier
Independent Director11yrsUS$222.37k0.13%
€ 1.0m
David Musket
Independent Director11yrsUS$237.36k0.20%
€ 1.6m
Francesco Muntoni
Member of Scientific Advisory Boardno datano datano data
Pat Furlong
Member of Scientific Advisory Boardno datano datano data
Eugenio Mercuri
Member of Scientific Advisory Boardno datano datano data
Craig McDonald
Member of Scientific Advisory Boardno datano datano data
Oscar Mayer
Member of Scientific Advisory Boardno datano datano data
Michelle Eagle
Member of Scientific Advisory Boardno datano datano data
Michael Taylor
Member of Scientific Advisory Board6.8yrsno datano data

11.0yrs

Average Tenure

68yo

Average Age

Experienced Board: 4LN2's board of directors are seasoned and experienced ( 11 years average tenure).